Daniel Joseph OConnell
President and CEO at Acumen Pharmaceuticals Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Acumen Pharmaceuticals Inc., 3 years.
Acumen Pharmaceuticals Inc.
Director · President and CEO
Chief executive roles
Acumen Pharmaceuticals Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 19, 2024 | Acumen Pharmaceuticals Inc. | Open-market sale | −15,200 | $3.47 | $52,744 |
| Jan 2, 2024 | Acumen Pharmaceuticals Inc. | Grant or award | +401,000 | — | — |
| Jan 17, 2023 | Acumen Pharmaceuticals Inc. | Grant or award | +114,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.